Full Text View
Tabular View
No Study Results Posted
Related Studies
Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions (CORAL)
This study is currently recruiting participants.
Study NCT00081731   Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: April 19, 2004   Last Updated: April 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Atherosclerosis
Cardiovascular Diseases
Hypertension, Renovascular
Renal Artery Obstruction
Additional conditions recognized in this trial
Hypertension
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Hypertension, Renal
Kidney Diseases
Urologic Diseases
Vascular Diseases
Interventions listed in this trial
Atacand
Angioplasty plus stenting
Additional drug interventions recognized in this trial
Candesartan cilexetil
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services